Radiogenomics: Creating a link between molecular diagnostics and diagnostic imaging

被引:227
作者
Rutman, Aaron M. [2 ]
Kuo, Michael D. [1 ,2 ]
机构
[1] Univ Calif San Diego, Med Ctr, Ctr Translat Med Syst, San Diego, CA 92103 USA
[2] Univ Calif San Diego, Med Ctr, Dept Radiol, San Diego, CA 92103 USA
关键词
Radiogenomics; Personalized medicine; Diagnostic imaging; GENE-EXPRESSION PATTERNS; GLIOBLASTOMA-MULTIFORME; DRUG RESPONSE; CANCER; PREDICTION; SUBTYPES; PHARMACOGENOMICS; CLASSIFICATION; CHEMOTHERAPY; PORTRAITS;
D O I
10.1016/j.ejrad.2009.01.050
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Studies employing high-throughput biological techniques have recently contributed to an improved characterization of human cancers, allowing for novel sub-classification, better diagnostic accuracy, and more precise prognostication. However, requirement of surgical procurement of tissue among other things limits the clinical application of such methods in everyday patient care. Radiographic imaging is routine in clinical practice but is currently histopathology based. The use of routine radiographic imaging provides a potential platform for linking specific imaging traits with specific gene expression patterns that inform the underlying cellular pathophysiology; imaging features could then serve as molecular surrogates that contribute to the diagnosis, prognosis, and likely gene-expression-associated treatment response of various forms of human cancer. This review focuses on high-throughput methods such as microarray analysis of gene expression, their role in cancer research, and in particular, on novel methods of associating gene expression patterns with radiographic imaging phenotypes, known as "radiogenomics." These findings underline a potential future role of both diagnostic and interventional radiologists in genetic assessment of cancer patients with radiographic imaging studies. (C) 2009 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:232 / 241
页数:10
相关论文
共 43 条
[21]   High-throughput biology in the postgenomic era [J].
Hsiao, Albert ;
Kuo, Michael D. .
JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY, 2006, 17 (07) :1077-1085
[22]   Molecular diagnostics as a predictive tool: genetics of drug efficacy and toxicity [J].
Johnson, JA ;
Evans, WE .
TRENDS IN MOLECULAR MEDICINE, 2002, 8 (06) :300-305
[23]   Targeting angiogenesis in cancer: clinical development of bevacizumab [J].
Kerr, David J. .
NATURE CLINICAL PRACTICE ONCOLOGY, 2004, 1 (01) :39-43
[24]   Radiogenomic analysis to identify imaging phenotypes associated with drug response gene expression programs in hepatocellular carcinoma [J].
Kuo, Michael D. ;
Gollub, Jeremy ;
Sirlin, Claude B. ;
Ooi, Clara ;
Chen, Xin .
JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY, 2007, 18 (07) :821-831
[25]   Gene expression profiling identifies clinically relevant subtypes of prostate cancer [J].
Lapointe, J ;
Li, C ;
Higgins, JP ;
van de Rijn, M ;
Bair, E ;
Montgomery, K ;
Ferrari, M ;
Egevad, L ;
Rayford, W ;
Bergerheim, U ;
Ekman, P ;
DeMarzo, AM ;
Tibshirani, R ;
Botstein, D ;
Brown, PO ;
Brooks, JD ;
Pollack, JR .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (03) :811-816
[26]   Classification and prediction of survival in hepatocellular carcinoma by gene expression profiling [J].
Lee, JS ;
Chu, IS ;
Heo, J ;
Calvisi, DF ;
Sun, ZT ;
Roskams, T ;
Durnez, A ;
Demetris, AJ ;
Thorgeirsson, SS .
HEPATOLOGY, 2004, 40 (03) :667-676
[27]   Gene expression profiling reveals molecularly and clinically distinct subtypes of glioblastoma multiforme [J].
Liang, Y ;
Diehn, M ;
Watson, N ;
Bollen, AW ;
Aldape, KD ;
Nicholas, MK ;
Lamborn, KR ;
Berger, MS ;
Botstein, D ;
Brown, PO ;
Israel, MA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2005, 102 (16) :5814-5819
[28]   Molecular determinants of the response of glioblastomas to EGFR kinase inhibitors [J].
Mellinghoff, IK ;
Wang, MY ;
Vivanco, I ;
Haas-Kogan, DA ;
Zhu, SJ ;
Dia, EQ ;
Lu, KV ;
Yoshimoto, K ;
Huang, JHY ;
Chute, DJ ;
Riggs, BL ;
Horvath, S ;
Liau, LM ;
Cavenee, WK ;
Rao, PN ;
Beroukhim, R ;
Peck, TC ;
Lee, JC ;
Sellers, WR ;
Stokoe, D ;
Prados, M ;
Cloughesy, TF ;
Sawyers, CL ;
Mischel, PS .
NEW ENGLAND JOURNAL OF MEDICINE, 2005, 353 (19) :2012-2024
[29]   EGFR mutations in lung cancer:: Correlation with clinical response to gefitinib therapy [J].
Paez, JG ;
Jänne, PA ;
Lee, JC ;
Tracy, S ;
Greulich, H ;
Gabriel, S ;
Herman, P ;
Kaye, FJ ;
Lindeman, N ;
Boggon, TJ ;
Naoki, K ;
Sasaki, H ;
Fujii, Y ;
Eck, MJ ;
Sellers, WR ;
Johnson, BE ;
Meyerson, M .
SCIENCE, 2004, 304 (5676) :1497-1500
[30]   A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer [J].
Paik, S ;
Shak, S ;
Tang, G ;
Kim, C ;
Baker, J ;
Cronin, M ;
Baehner, FL ;
Walker, MG ;
Watson, D ;
Park, T ;
Hiller, W ;
Fisher, ER ;
Wickerham, DL ;
Bryant, J ;
Wolmark, N .
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 351 (27) :2817-2826